Nature Charts OPASI Cartographer

That would be the new Director of the Office of Portfolio Analysis and Strategic Initiatives (OPASI), Alan Krensky. Nature has a nice recap of his initial days on the job and plans for the future, which apparently will include moving on at the end of 2008 to direct the Division of Program Coordination, Planning and Strategic Initiatives (DPCPSI), of which OPASI will be a member (so will the Office of AIDS Research and the Office for Research on Women’s Health). Maybe he’ll be promoted to run something with even more letters in its abbreviation by the end of his tenure. Seems promising that he’ll make some sense of the Roadmap in the meantime.

2 Comments »

  1. writedit said

    Already, Dr. Krensky is moving on to more inviting pastures at NCI it seems:

    From: Exec Sec1 (NIH/OD)
    To: XXX
    Sent: Tue Nov 04 10:12:54 2008
    Subject: IMPORTANT Announcement from the Acting Director
    TO: IC Directors, OD Senior Staff, and OPASI Staff
    FROM: Acting Director, NIH

    SUBJECT: Designation of Lana R. Skirboll, Ph.D., as Acting Director,
    Division of Program Coordination, Planning, and Strategic Initiatives, and Organization of the Division

    We are working to stand up the newly announced Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI). The new Division is composed of four program offices, including OBSSR, ORWH, OAR, and ODP, as well as the functions under the former OPASI. The former Division of Strategic Coordination in OPASI will be reconstituted as the Office of Strategic Initiatives, while the other OPASI functions will be moved into the Office of the DPCPSI Director.

    Dr. Alan Krensky, former Director of OPASI, is transitioning to his laboratory in NCI and will also serve as Senior Advisor to the NIH Deputy Director. We are indebted to Alan for his contributions to developing OPASI and thank him for his service.

    Dr. Lana Skirboll will serve as Acting Director of the new Division. I am grateful that Lana is willing to take on this important leadership position, as we fully implement the NIH Reform Act. Lana brings a wealth of experience to this new role. She received her Ph.D. in Pharmacology at Georgetown and did her postdoctoral training at Yale and the Karolinska Institute. As Director of the NIH Office of Science Policy (OSP), Lana has provided national leadership on a myriad of science policy issues. She also played a pivotal role in the launching of the NIH Roadmap for Medical Research.

    Dr. Amy Patterson, currently the Director of the Office of Biotechnology Activities in OSP, will be Acting Director of OSP. She received her M.D.
    from the Albert Einstein College of Medicine and completed internal medicine residency at the Memorial Sloan Kettering Cancer Center and New York Hospital where she served as Assistant Chief Resident. Following her postdoctoral fellowships at the NIH. Amy was at the FDA, where she had increasing levels of responsibility, before returning to the NIH.

    I know I can count on you to give Lana and Amy your full support as they take on these new responsibilities.

    Raynard S. Kington, M.D., Ph.D.

  2. […] not covered, at least in the PowerPoints, is the departure of Alan Krensky as Director of OPASI, as I noted previously, “to his laboratory in NCI and … Senior Advisor to the NIH Deputy Director” (now […]

RSS feed for comments on this post · TrackBack URI

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: